Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Name
Division of Pediatric Infectio
Department
Type
DUNS #
City
State
Country
Zip Code
Hartman, Lauren; Zhu, Yuwei; Edwards, Kathryn M et al. (2018) Underdiagnosis of Influenza Virus Infection in Hospitalized Older Adults. J Am Geriatr Soc 66:467-472
Talbot, H Keipp; Nian, Hui; Chen, Qingxia et al. (2016) Evaluating the case-positive, control test-negative study design for influenza vaccine effectiveness for the frailty bias. Vaccine 34:1806-9
Chen, Qingxia; Griffin, Marie R; Nian, Hui et al. (2015) Influenza vaccine prevents medically attended influenza-associated acute respiratory illness in adults aged ?50 years. J Infect Dis 211:1045-50
Lindegren, Mary Louise; Griffin, Marie R; Williams, John V et al. (2015) Antiviral treatment among older adults hospitalized with influenza, 2006-2012. PLoS One 10:e0121952
Gilchuk, Pavlo; Spencer, Charles T; Conant, Stephanie B et al. (2013) Discovering naturally processed antigenic determinants that confer protective T cell immunity. J Clin Invest 123:1976-87
Klemenc, Jennifer; Asad Ali, S; Johnson, Monika et al. (2012) Real-time reverse transcriptase PCR assay for improved detection of human metapneumovirus. J Clin Virol 54:371-5
Prill, Mila M; Iwane, Marika K; Edwards, Kathryn M et al. (2012) Human coronavirus in young children hospitalized for acute respiratory illness and asymptomatic controls. Pediatr Infect Dis J 31:235-40
Widmer, Kyle; Zhu, Yuwei; Williams, John V et al. (2012) Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis 206:56-62
Thomsen, Isaac; McKenna, Brian D; Saye, Elizabeth J et al. (2011) Molecular distinctions exist between community-associated methicillin-resistant Staphylococcus aureus colonization and disease-associated isolates in children. Pediatr Infect Dis J 30:418-21
Frenck Jr, Robert W; Belshe, Robert; Brady, Rebecca C et al. (2011) Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (FluzoneĀ®) administered by intradermal and intramuscular route in healthy adults. Vaccine 29:5666-74

Showing the most recent 10 out of 40 publications